Shinoda Tomohito, Tanahashi Toshiyuki, Sakuratani Takuji, Ota Masato, Fujibayashi Seito, Kiriyama Shunya, Matsumoto Keita, Yawata Kazunori, Sasaki Yoshiyuki, Osada Shinji, Yamada Makoto
Department of Surgery, Gifu Municipal Hospital, Gifu 500-8513, Japan.
Mol Clin Oncol. 2022 Jan;16(1):11. doi: 10.3892/mco.2021.2441. Epub 2021 Nov 14.
Pseudocirrhosis is a rare but important complication of metastatic cancer. We herein present the case of a patient with pseudocirrhosis occurring after a complete response to chemotherapy for metastatic gastric cancer was achieved. A 72-year-old man was diagnosed with gastric adenocarcinoma with multiple liver metastases. The patient's general condition was good, with an Eastern Cooperative Oncology Group performance status of 1. Chemotherapy with oxaliplatin and S-1 was initiated and, after four cycles, the patient noticed sudden abdominal distension. Despite the marked regression of the liver metastases, massive ascites, segmental atrophy and esophageal varices developed, findings consistent with pseudocirrhosis. The patient achieved complete response for the primary and metastatic lesions. Following endoscopic ligation of the varices, he underwent subsequent chemotherapy with S-1 only and management of his ascites for 6 months. At 12 months after initial chemotherapy, the patient appeared to be disease-free. In conclusion, clinicians should be aware of the possibility of pseudocirrhosis in cases of cancer metastasis to the liver, including metastatic gastric cancer.
假性肝硬化是转移性癌症一种罕见但重要的并发症。我们在此报告一例在转移性胃癌化疗取得完全缓解后发生假性肝硬化的患者。一名72岁男性被诊断为胃腺癌伴多发肝转移。患者一般状况良好,东部肿瘤协作组体能状态评分为1分。开始使用奥沙利铂和S-1进行化疗,四个周期后,患者突然出现腹胀。尽管肝转移灶明显消退,但出现了大量腹水、节段性萎缩和食管静脉曲张,这些表现符合假性肝硬化。患者的原发灶和转移灶均达到完全缓解。在内镜下结扎静脉曲张后,他仅接受了S-1后续化疗并进行了6个月的腹水管理。初始化疗后12个月,患者似乎无疾病迹象。总之,临床医生应意识到癌症转移至肝脏(包括转移性胃癌)时出现假性肝硬化的可能性。